Apyx Medical Corp. Files 8-K on Financials
Ticker: APYX · Form: 8-K · Filed: Jan 13, 2025 · CIK: 719135
| Field | Detail |
|---|---|
| Company | Apyx Medical Corp (APYX) |
| Form Type | 8-K |
| Filed Date | Jan 13, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-K, company-update
Related Tickers: APYX
TL;DR
Apyx Medical (APYX) filed an 8-K on Jan 13, 2025, with financial updates.
AI Summary
Apyx Medical Corp. filed an 8-K on January 13, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits related to the period ending January 13, 2025. The company, formerly known as Bovie Medical Corp., is incorporated in Delaware and headquartered in Clearwater, Florida.
Why It Matters
This filing provides investors with updated financial information and operational results for Apyx Medical Corp., crucial for assessing the company's performance and future prospects.
Risk Assessment
Risk Level: low — This is a routine financial filing (8-K) and does not appear to contain any immediately alarming or significant new information beyond standard reporting requirements.
Key Players & Entities
- Apyx Medical Corp. (company) — Registrant
- Bovie Medical Corp. (company) — Former company name
- January 13, 2025 (date) — Filing date and period of report
- Clearwater, Florida (location) — Principal executive offices
FAQ
What specific financial results are being reported in this 8-K?
The filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits', but the specific figures are not detailed in the provided header information.
When was this 8-K filed and what period does it cover?
The 8-K was filed on January 13, 2025, and it reports on the period ending January 13, 2025.
What is the principal business address of Apyx Medical Corp.?
The principal executive offices are located at 5115 Ulmerton Road, Clearwater, Florida 33760.
Has Apyx Medical Corp. always been known by this name?
No, the company was formerly known as Bovie Medical Corp. and prior to that, AN CON GENETICS INC.
What is the SIC code for Apyx Medical Corp.?
The Standard Industrial Classification (SIC) code is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
Filing Stats: 507 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2025-01-13 08:00:33
Filing Documents
- apyx20250110_8k.htm (8-K) — 25KB
- ex_764255.htm (EX-99.1) — 16KB
- apyx20240909_8kimg001.jpg (GRAPHIC) — 7KB
- logo.jpg (GRAPHIC) — 8KB
- 0001437749-25-000927.txt ( ) — 204KB
- apyx-20250113.xsd (EX-101.SCH) — 3KB
- apyx-20250113_def.xml (EX-101.DEF) — 11KB
- apyx-20250113_lab.xml (EX-101.LAB) — 15KB
- apyx-20250113_pre.xml (EX-101.PRE) — 11KB
- apyx20250110_8k_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition On January 13, 2025, Apyx Medical Corporation (the "Company") issued a press release reporting on its preliminary revenue results for the fourth quarter and year ended December 31, 2024. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 2.02 and shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. This report will not be deemed an admission as to the materiality of any information herein (including Exhibit 99.1).
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibits. Exhibit No. Description 99.1 Press release dated January 13, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 13, 2025 Apyx Medical Corporation By: /s/ Matthew Hill Matthew Hill Chief Financial Officer, Secretary and Treasurer